Stephen Anastos

Stephen Anastos is a Managing Director at Deerfield Management, where he invests in healthcare across early venture stages, including Series A and Series C. His focus spans Healthcare Services & Technology, Life Sciences, Medical Devices, Diagnostics, Digital Health, Health Services, Biotechnology, Therapeutics, and Clinical Trials. He invests across the United States and North America, with activity in California, Massachusetts, and the broader New England region. He has invested in companies like Cohere Health, ConcertoCare, RubiconMD, AbleTo, and Novocardia. Before Deerfield, he served as Director of the MassHealth ACO Program at the Massachusetts Executive Office of Health and Human Services and was previously a Principal and Associate at Bain Capital Ventures; earlier roles include Digital Health Incubations at Blueprint Health and Analyst/Senior Analyst at Altman Vilandrie & Company. Stephen graduated from Harvard University and lives in New York.